IPO Boutique

Voyager Therapeutics IPO Advisory

Share this IPO Profile:

Smart Search
Company begins with...
Company contains...

For IPO Boutique's "scale of 1 to 5" BUY rating on Voyager Therapeutics, and our comprehensive analysis, click "Buy Market Research".
Company
Symbol
Price Range
Issue Price
Open
Shares
Trade Date
Voyager TherapeuticsVYGR -
NASDAQ
$15.00-$17.00 $14.00 $15.105 million11/11/2015
Cowen & Co., Piper Jaffray, Nomura, Wedbush PacGrow
Co-Manager(s):
Health Care
Filing(s):

Filed 2015-10-09
Terms Added 2015-10-30



Voyager Therapeutics Quote & Chart - Click for current quote - VYGR

About Voyager Therapeutics (adapted from Voyager Therapeutics prospectus):
They are a clinical-stage gene therapy company focused on developing life-changing treatments for patients suffering from severe diseases of the central nervous system, or CNS.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.



IPO Boutique aggregates information on public companies and private companies, such as "VYGR" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.

Used our Comprehensive Single Promo Advisory and want more?
We also offer a monthly or annual subscription






© 2005 - 2024 IPO Boutique. All Rights Reserved